top of page
News, Events and Updates
Search
May 21, 2020
Anavex Life Sciences Announces Initiation of First-in-Human Phase 1 Study of ANAVEX®3-71 (AF710B)
May 7, 2020
Anavex Life Sciences Reports Fiscal 2020 2nd Quarter Financial Results And Provides Business Updates
May 5, 2020
Anavex Life Sciences to Announce Fiscal 2020 Second Quarter Financial Results
Apr 23, 2020
Anavex Life Sciences Announces Publication of Clinical Data for ANAVEX®2-73 in Alzheimer's Disease
Mar 31, 2020
Anavex Life Sciences Provides Update on Clinical Program Development as Response to COVID-19
Mar 23, 2020
Anavex Life Sciences to Webcast 2020 Annual Meeting of Shareholders
Feb 24, 2020
Anavex Life Sciences Announces Foundational Data for ANAVEX®2-73 in Multiple Sclerosis (MS)
Feb 6, 2020
Anavex Life Sciences Reports Fiscal 2020 1st Quarter Financial Results
Feb 3, 2020
Anavex Life Sciences Announces Fast Track Designation Granted by US FDA for ANAVEX®2-73 Development
Jan 30, 2020
Anavex Life Sciences to Announce Fiscal 2020 First Quarter Financial Results on Thursday, 2/6/2020
Jan 27, 2020
Anavex Life Sciences Announces Achievement of Enrollment Target for ANAVEX®2-73 Phase 2 PDD Trial
14
15
16
17
18
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
